GlaxoSmithKline Consumer Healthcare Limited Financial Results Quarter 4 - FY 2018-19 & Financial Year 2018-19

Quarter Highlights Revenue increased by 9% (Volume Growth 6.5%) Growth is across portfolio and channels. Rural growth continues to accelerate in double digit. PBT increased by 34% Continued investment behind brands: 13% vs LY to fund innovation & drive Horlicks campaign Drive HFD Consumption Brand building initiatives, continue to strengthen / expand the initiatives: The “Better Protein” launch campaign emphasized on Triple Blend Protein story to establish product superiority. Digital campaign for Women Horlicks covering Real Stories of Strength of Successful women. BOOSTCAMP, a platform for training young kids for varied sports, signifying more” Energy”, “stamina” and “Winning” among kids. Sachet volume continue to grow high double digit, led by visible distribution & strong on-air support.

Financial Performance: Q4 FY18-19 Net Sales Q4 FY 18-19

Financial Performance: Financial Year 18-19 * Comparable revenue growth of 12% Net Sales FY 18-19

Horlicks continues to be at first position in HFD category Market Share Brand Volume Value Horlicks 49.5% Horlicks 42.9% Boost 14.0 % Boost 10.7 % Horlicks continues to be at first position in HFD category Source – AC Nielsen; Market Share MAT Mar 19

Thank You